Practice‐Changing Advances in Systemic Therapies Shaping the Landscape of Lung Cancer in 2025
Cancer Innovation · 2026-06 · 5 (3)
DOI: 10.1002/cai2.70064 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Innovation, online erschienen am 24.05.2026. Verfasst von Zhenyu Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences Southern Medical University Guangzhou …. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
With the rapid advancement of molecular profiling and precision therapeutics, targeted and immunotherapeutic strategies have irrevocably reshaped the pharmacological management for both non‐small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Overall mortality from lung cancer has continued its downward trend over the past decade, and this decline has accelerated, largely driven by advances in early detection and curative‐intent surgeries. In parallel, the systemic therapies have undergone a dramatic evolution with the integration of, for example, antibody‐drug conjugates (ADCs) and bispecific antibodies (BsAbs). The year 2025 marks a period of significant progress in lung cancer treatment, characterized by groundbreaking therapeutic successes across all disease stages and subtypes. This comprehensive review synthesizes pivotal evidence presented at key oncology forums in 2025 to delineate the substantially evolved clinical landscape.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences Southern Medical University Guangzhou Guangdong China.
- Shantou University Medical College Shantou Guangdong China.
- Department of Clinical Oncology The Chinese University of Hong Kong Hong Kong China.
ORCID-Profile: Qing Zhou
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhou, Z., Gao, W., Li, M. S. C., & Zhou, Q. (2026). Practice‐Changing Advances in Systemic Therapies Shaping the Landscape of Lung Cancer in 2025. Cancer Innovation, 5(3). https://doi.org/10.1002/cai2.70064
Vancouver
Zhou Z, Gao W, Li MSC, Zhou Q. Practice‐Changing Advances in Systemic Therapies Shaping the Landscape of Lung Cancer in 2025. Cancer Innovation. 2026;5(3). doi:10.1002/cai2.70064
BibTeX
@article{Zhou2026,
author = {Zhou, Zhenyu and Gao, Wanting and Li, Molly S C and Zhou, Qing},
title = {Practice‐Changing Advances in Systemic Therapies Shaping the Landscape of Lung Cancer in 2025},
journal = {Cancer Innovation},
year = {2026},
volume = {5},
number = {3},
doi = {10.1002/cai2.70064}
}
EUVIMED